AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitasys M 50mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Systopic Laboratories Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitasys M 50mg/500mg Tablet PR

Diabexe Duo 50mg/500mg tablets are a dual-action medication managing elevated blood glucose in type 2 diabetes. This helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. Diabexe Duo may be used independently or alongside other anti-diabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose readings, and concurrent medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Continued commitment to the prescribed diet and exercise plan is crucial for effective diabetes management, as lifestyle significantly impacts blood sugar control. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; proper recognition and management of low blood sugar is essential. This medication is not universally appropriate. Prior to commencement, inform your physician of any history of cardiac, hepatic, or renal disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel before use. Interactions with other medications are possible; disclose all current medications to ensure treatment safety. Alcohol should be minimized due to its potential to exacerbate hypoglycemia. Kidney function and blood glucose will be monitored by your doctor throughout treatment.

Uses of Sitasys M 50mg/500mg Tablet PR

Managing type 2 diabetes

Major Benefits of Sitasys M 50mg/500mg Tablet PR:

Follow your physician's instructions or consult the product label for dosage guidance. Administer Sitasys M 50mg/500mg Tablet PR with a meal.

Common Side effects of Sitasys M 50mg/500mg Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitasys M 50mg/500mg Tablet PR:

Always follow your physician's instructions or consult the product information leaflet for proper usage. Take Sitasys M 50mg/500mg Tablet PR with a meal.

How Sitasys M 50mg/500mg Tablet PR works:

Sitasys M, a 50mg/500mg tablet, combines sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitasys M 50mg/500mg Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitasys M 50mg/500mg Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with a doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitasys M 50mg/500mg tablets during breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitasys M 50mg/500mg Tablet PR cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Use of Sitasys M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitasys M 50mg/500mg Tablet PR :

Should you forget a Sitasys M 50mg/500mg Tablet PR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitasys M 50mg/500mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Sitasys M 50mg/500mg Tablet PR

Sitasys M 50mg/500mg Tablets are a combination of sitagliptin and metformin, used to treat type 2 diabetes in adults. This medication improves blood sugar control when combined with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Prolonged use of Sitasys M 50mg/500mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance issues), and urinary problems, potentially impacting mental state. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitasys M 50mg/500mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitasys M 50mg/500mg Tablet PR is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasys M 50mg/500mg Tablet PR with alcohol is unsafe and may raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitasys M 50mg/500mg Tablet PR) can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency characterized by excessive blood lactic acid. This rare side effect necessitates avoiding this medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Sitasys M 50mg/500mg Tablets are a combined treatment for type 2 diabetes in adults, containing sitagliptin and metformin. This medication improves blood sugar control when used with a healthy diet and regular exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitasys M 50mg/500mg Tablet PR may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Sitasys M 50mg/500mg Tablet PR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasys M 50mg/500mg Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitasys M 50mg/500mg) can, rarely, cause lactic acidosis—a serious, potentially life-threatening buildup of lactic acid in the blood (also known as MALA, Metformin-associated lactic acidosis). This risk is higher in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and a slow heart rate. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitasys M 50mg/500mg Tablet PR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as numbness, tingling in the extremities, weakness, urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitasys M 50mg/500mg Tablets are a combined sitagliptin and metformin treatment for type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Sitasys M 50mg/500mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitasys M 50mg/500mg Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitasys M 50mg/500mg Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitasys M 50mg/500mg) can cause lactic acidosis (MALA), a serious medical emergency resulting from excess blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitasys M 50mg/500mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Sitasys M 50mg/500mg Tabl...
73
MRP 85
14% off